Department of General and Visceral Surgery, Robert Bosch Hospital, Stuttgart, Germany.
Laryngoscope. 2012 Sep;122(9):1979-87. doi: 10.1002/lary.23411. Epub 2012 Aug 1.
OBJECTIVES/HYPOTHESIS: Intraoperative neuromonitoring (IONM) facilitates recurrent laryngeal nerve (RLN) identification, but various studies affirm virtually unchanged postoperative RLN palsy rates. Several authors meanwhile suggest continuous intraoperative neuromonitoring (CIONM) via vagal nerve stimulation (VNS) to improve RLN protection. However, knowledge of side effects of electrical VNS derives mainly from its therapeutic applications in the fields of neurology and psychiatry. The presented study was conducted to further evaluate the safety of CIONM and identify possible VNS related side effects.
Prospective nonrandomized controlled trail.
Forty patients scheduled for thyroid or parathyroid surgery were enrolled in the trail. The intervention group consisted of 22 patients receiving VNS for CIONM. Eighteen patients were operated on with routine IONM. To assess VNS-induced effects on the autonomic nervous system (ANS), heart rate variability analysis (HRVA) was applied. Serum cytokine levels of tumor necrosis factor (TNF)-α were monitored to evaluate immunomodulatory effects of VNS.
HRVA revealed significantly increased vagal activity during CIONM. This parasympathetic predominance was not countered by the sympathetic nervous system. Despite a significant increase of vagal tone, no hemodynamic events occurred; in fact, no significant changes in median heart rate or in median arterial blood pressure were detected. Even though anti-inflammatory effects of VNS have been reported, no attenuation of cytokine release of TNF-α was measured.
VNS for CIONM resulted in increased vagal activity assessable via HRVA. The increased parasympathetic tone affected neither hemodynamics nor levels of the proinflammatory cytokine TNF-α. VNS for CIONM appears safe with the applied settings.
目的/假设:术中神经监测(IONM)有助于识别喉返神经(RLN),但多项研究证实术后 RLN 麻痹发生率几乎不变。同时,一些作者建议通过迷走神经刺激(VNS)进行连续术中神经监测(CIONM)以改善 RLN 保护。然而,电 VNS 的副作用知识主要来自其在神经病学和精神病学领域的治疗应用。本研究旨在进一步评估 CIONM 的安全性并确定可能与 VNS 相关的副作用。
前瞻性非随机对照试验。
40 名计划行甲状腺或甲状旁腺手术的患者入组本试验。干预组包括 22 名接受 VNS 进行 CIONM 的患者。18 名患者接受常规 IONM 手术。为评估 VNS 对自主神经系统(ANS)的影响,应用心率变异性分析(HRVA)。监测肿瘤坏死因子(TNF)-α的血清细胞因子水平,以评估 VNS 的免疫调节作用。
HRVA 显示 CIONM 期间迷走神经活性显著增加。这种副交感神经优势并没有被交感神经系统抵消。尽管迷走神经张力显著增加,但没有发生血液动力学事件;实际上,未检测到中位心率或中位动脉血压的显著变化。尽管已经报道了 VNS 的抗炎作用,但未测量到 TNF-α释放的抑制。
CIONM 中的 VNS 导致可通过 HRVA 评估的迷走神经活性增加。增加的副交感神经张力既不影响血液动力学,也不影响促炎细胞因子 TNF-α的水平。在应用的设置下,VNS 用于 CIONM 似乎是安全的。